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Abstract Liver cells express a wide range of extracellular e- 
ceptors involved in the control of cell growth and arrest that can 
be studied ex vivo. Incubation of primary cultures of hepatocytes 
with IL-lfl, TNF-~ or lipopolysaccharide promotes the expres- 
sion of the inducible form of nitric oxide synthase and NO release, 
a process that is inhibited to a different extent by incubation of 
the cells with EGF. In addition to this growth factor, IL-6 and 
TGF-fl also inhibited NO synthesis. Therefore, EGF by itself or 
in combination with other cytokines may be involved in the down- 
regulation of the NO synthesis that occurs in the early steps of 
liver regeneration. 
lated with an array of cytokines. Our results how an inhibitory 
role for EGF in the induction of iNOS by IL-lfl and TNF-~ 
and suggest that this growth factor by itself or in combination 
with other cytokines may participate in the down-regulation f 
the iNOS induced by some of the cytokines involved in the 
regenerating response of liver after pathological or surgical 
injury [11]. A similar role for EGF has been proposed in ker- 
atinocytes, where this growth factor antagonizes NO synthesis 
and the release of reactive oxygen intermediates [12], and in 
hippocampal neurons, where it prevents NO toxicity [13]. 
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1. Introduction 
Cell growth and differentiation require the coordinate pres- 
ence of extracellular factors and their corresponding functional 
plasma membrane receptors. In the case of liver, at least in the 
adult animal, most of the cell population is growth arrested in 
the G1/G0 phase of the division cell cycle, although epatocytes 
express receptors for different cytokines and growth factors 
and display one of the highest ranscriptional rates in the organ- 
ism [1,2]. In this r~gard, liver cells possess a high number of 
functional EGF receptors that in the presence of EGF  mediate 
an important proliferative response either in vivo or when 
hepatocytes are kept in primary culture, especially if additional 
signaling (i.e. c-myc induction) occurs [24]. Therefore, a role 
for EGF has been proposed in liver development and differen- 
tiation although the ability of the fetus to produce EGF has 
been questioned by several authors, proposing a maternal ori- 
gin for the EGF present in fetal and neonatal liver [5,6]. 
Recently, it has been shown that in the early steps of liver 
regeneration NO is released in the tissue and although the 
physiological significance of this process is a matter of debate, 
a role for NO in the decrease of liver damage and in regenera- 
tion has been proposed [7-9]. NO is released after induction of 
iNOS by endotoxins, such as LPS, or by cytokines produced 
in the course of the liver injury, especially TNF-~. iNOS expres- 
sion is controlled by a complex regulatory mechanism involving 
several different rans activating factors [10] and, presumably, 
the temporal pattern of release of inhibitory cytokines may 
block NO synthesis after liver regeneration. 
In this work we have investigated whether EGF may modu- 
late the NO release in primary cultures of hepatocytes stimu- 
*Corresponding author. Fax: (34) (1) 543-8649 or (34) (1) 394-1782. 
Abbreviations." LPS, lipopolysaccharide; iNOS, nitric oxide synthase; 
EGF, epidermal growth factor. 
2. Materials and methods 
2.1. Materials 
[~-nP]dCTP (6000 Ci/mmol) was from Amersham. Tissue culture 
dishes were from Costar or Falcon and culture media from Bio- 
whitaker. Substrates, cytokines, enzymes and coenzymes were obtained 
from Boehringer, Sigma or Merck. Hormones were tested for en- 
dotoxin content that was below 1 ng/mg using the Limulus polyphemus 
test (Sigma). 
2.2. Isolation of adult and fetal hepatocytes 
Adult hepatocytes were prepared from 3-month-old male rats using 
a recirculating perfusion medium containing 1 mg/ml of collagenase H, 
and following a previous protocol [8]. Fetal hepatocytes were prepared 
from chopped livers of 21-day-old fetuses using a non-perfusion col- 
lagenase dispersion method that involved incubation for 30 min at 37°C 
with Ca2+-free Krebs-bicarbonate buffer containing 0.5 mM EGTA, 
under continuous gassing with carbogen (O/CO2, 19:1) [14]. To deplete 
the preparation of Kupffer cells, the cells were kept for 1 h in Costar 
plastic dishes (4 x 105 cells/cm 2) and the non-adherent cells were trans- 
ferred to collagen-coated Falcon dishes, 2 h in the presence of 10% FCS 
and 4 additional hours in phenol red- and serum-free DMEM. 
2.3. Measurement of nitrites and nitrates 
NO release was determined spectrophotometrically by the accumula- 
tion of nitrite and nitrate in the medium (phenol red-free) as follows: 
250/21 of culture medium were transferred to 1.5 ml Eppendorf tubes 
and the nitrate was reduced to nitrite with 0.5 units of nitrate reductase 
(Boehringer) in the presence of 50/2M NADPH, 5/2M FAD [8]. The 
excess of NADPH was oxidized in the presence of 0.2 mM pyruvate and 
1 /2g of lactate dehydrogenase. Nitrite was determined with Griess 
reagent [15] by adding 1 mM sulfanilic acid and 100 mM HC1 (final 
concentration). After incubation for 5 min the tubes were centrifuged 
and 200/21 of supernatant were transferred to a 96-well plate. After a 
first reading of the absorbance at 548 nm, 1 mM of naphthylenediamine 
was added and the absorbance at 548 nm was compared with a standard 
of NaNO2. 
2.4. RNA extraction and analysis 
Total RNA (34 × 10 6 cells) was extracted following the guanidinium 
thiocyanate method [16]. After electrophoresis in a 0.9% agarose gel 
containing 2% formaldehyde the RNA was transferred toNytran mem- 
branes and the level of iNOS mRNA was determined using an EcoRI/ 
HindlII fragment from the iNOS cDNA [8], labeled with [~-nP]dCTP 
using the Random Primed Labeling Kit (Boehringer). Quantification 
of the films was performed by laser densitometry (molecular dynamics), 
using the hybridization with a fl-actin probe (0.6 kb EcoRIIHindlII 
fragment isolated from a VC 18 vector) as an internal standard. 
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Fig. 1. EGF inhibits cytokine-dependent NO release. Primary cultures of fetal (A) or adult (B and C) hepatocytes were incubated with 10 ng/ml of 
IL-lfl or TNF-~ or 0.5 ,ug/ml of LPS in the absence (open bars) or presence (cross-hatched bars) of 10 nM EGF and the NO release was measured 
after 24 h. The time course for NO release in cells treated with TNF-c~ is shown in C. Results show the mean + S.E.M. of 3 cell cultures. 
2.5. iNOS enzyme activity assay 
iNOS activity was measured after partial purification by 2',5'-ADP- 
Sepharose chromatography and was followed by the production of 
[U-~4C]citrulline from [U-~4C]arginine [17]. The reaction mixture con- 
tained 50/.tM [U-~4C]arginine (0.3 ,uCi), 20 mM HEPES (pH 7.5), 0.5 
mM NADPH, 0.1 mM DTE, 10/IM 6R-5,6,7,8-tetrahydro-L-biopterin 
(BH4, Dr. B. Schirck's Laboratories, Jona, CH) (200/11 of incubation 
volume). After 10 min of incubation, 1ml of ice-cold 10 mM EGTA, 
0.1 mM citrulline, 10 mM Pipes; pH 5.5 was added and 1 ml of this 
mixture was applied to a 1 ml Dowex AG50W-X8 column (Na ÷ form). 
[U-~4C]Citrulline was eluted in 3 ml of water and the radioactivity was 
counted. The enzyme activity was expressed as the difference of product 
formation in the absence or presence of 0.25 mM NG-methyl-L-arginine 
in the reaction mixture [8]. 
3.  Resu l ts  
3.1• EGF antagonizes NO release in hepatocytes treated with 
IL-I~, TNF-c~ or LPS  
Because EGF  receptors vary along development [5,18] we 
used fetal and adult hepatocytes todetermine the effect of EGF  
on cytokine-dependent NO synthesis. Exposure of cultured 21- 
day-old fetal (Fig. 1A) or adult (Fig. 1B) hepatocytes to IL-lfl, 
TNF-~ or LPS promoted the release of NO-derived products 
(nitrites and to a lesser extent nitrates) after 24 h of culture. This 
effect was roughly twice in adult than in fetal hepatocytes under 
identical experimental conditions. When fetal or adult hepato- 
cytes were incubated with EGF and then stimulated with these 
iNOS inducers, a blockage in the synthesis of NO was observed 
and the relative inhibitory effect exerted by EGF  was independ- 
ent of the developmental stage of the hepatocytes. Therefore, 
no differences between fetal and adult hepatocytes can be ob- 
served in the response to EGF in this experimental system; and 
because of the higher response of adult hepatocytes, these cells 
were used in the following experiments. Fig. 1C shows the time 
course for NO release in adult hepatocytes incubated with 
TNF-~ as a representative cytokine, and the maximal rate of 
release was obtained between 18 and 24 h of incubation. The 
inhibitory effect exerted by EGF  on this model was constant 
along this time, and similar results were obtained for IL-lf l  and 
LPS (not shown). 
To study the inhibitory effect of EGF on the NO release 
elicited by stimulatory cytokines a titration was carried out 
using a constant saturant EGF  concentration and increasing 
amounts of IL- lf l  or TNF-~. As Fig. 2 shows, EGF  inhibited 
85% and 60% of the NO synthesis elicited by concentrations 
below 2 ng/ml of IL- lf l  and TNF-~, respectively. However, 
concentrations of EGF up to 100 nM were unable to inhibit 
more than 60% of the NO release licited by a saturant concen- 
tration of TNF-~, suggesting that several intracellular signaling 
pathways operate to promote iNOS expression in response to 
cytokines and only some of them are affected through EGF 
signaling. 
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Fig. 2. Inhibition by EGF of NO release in cells treated with IL-lfl or 
TNF-c¢. Adult hepatocytes were incubated in the absence (open bars) 
or presence (cross-hatched bars) of 10 nM EGF and the indicated 
cytokine concentration a d the NO release were followed for a period 
of 24 h. Insets show the corresponding inhibition exerted by EGF for 
each panel. Results correspond to the mean + S.E.M. of 3 experiments. 
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Fig. 3. Desensitization f EGF receptors inthe inhibition of NO release. 
Hepatocytes were incubated with 10 nM EGF for the indicated periods 
followed by stimulation with TNF-~ or LPS. The NO release during 
the following 24 h was measured. Results how the mean _+ S.E.M. of 
3 experiments. 
Since EGF binding to the cell involves arapid internalization 
of the membrane EGF receptors and a concomitant desensiti- 
zation of the cell to this growth factor, hepatocytes were incu- 
bated for different times with EGF followed by triggering with 
TNF-~ or LPS and the NO release was measured 24 h later. 
As Fig. 3 shows a time-dependent desensitization to the inhib- 
itory effect of EGF was observed for the induction elicited by 
TNF-~ or LPS revealing the necessity of a functional EGF 
receptor to mediate the inhibitory response. In addition to 
EGF, other cytokines relevant o hepatocyte function were 
tested. TGF-fl resulted very effective in preventing iNOS induc- 
tion by IL-lfl, TNF-~ and LPS, whereas moderate inhibitory 
effects were observed when cells were stimulated with IL-6 
(Table 1). Therefore, the cooperative r sponse to combinations 
of EGF with TGF-fl or IL-6 might provide mechanisms to 
improve iNOS inhibition by these cytokines. 
3.2. EGF antagonizes iNOS expression in response to cytokines 
To ensure that the inhibitory effect exerted by EGF on the 
cytokine induction of iNOS was due to a decreased expression 
of this enzyme, mRNA levels and enzyme activity were meas- 
Table 1 
Modulation of NO release by TGF-fl and IL-6 
Addition IL- lfl TNF-c~ LPS 
(10 ng/ml) (10 ng/ml) (0.5 pg/ml) 
None 10.5 + 0.8 16.3 + 1.0 18.7 + 1.4 
TGF-fl, 10 ng/ml 2.6 + 0.3 5.8 + 0.7 11.6 + 0.9 
+ EGF, 10 ng/ml 0.2 1.1 + 0.1 2.1 + 0.2 
IL-6, 10 ng/ml 6.2 + 0.5 8.8 + 0.7 14.2 + 1.1 
+ EGF, 10 ng/ml 1.5 _+ 0.1 1.7 + 0.2 4.8 + 0.3 
Cultured hepatocytes were incubated for 24 h with the indicated cytok- 
ines, and the release of NO was measured. Results show the 
means + S.E.M. of 3 cell preparations. 
ured in hepatocytes. As Fig. 4 shows, decreased mRNA levels 
of iNOS were observed in the response to cytokines in cells 
treated with EGF. Accordingly, a lower iNOS activity was 
present in cells incubated with EGF and then stimulated with 
IL-lfl, TNF-~ or LPS, in agreement with data on NO release 
to the medium. 
4. Discussion 
The ability of hepatocytes to express iNOS in response to 
cytokines is now well accepted, despite the controversy that 
existed in previous reports [7,8,19]. The synthesis of NO in 
regenerating liver after partial hepatectomy or in the liver of 
animals suffering septic shock is probably the result of the 
concerted action of various cytokines, among them TNF-ct, 
that are released uring the early steps following liver injury 
[1,20,21]. However, this release of NO is important in the first 
24 h of the regenerative r sponse, and both NO synthesis and 
iNOS expression rapidly decrease after this period to be com- 
pletely absent in normal iver [7,8]. Therefore, NO release in 
liver is restricted to events associated with commitment for cell 
growth, and preliminary experiments suggest that in its absence 
the distribution of cells in the cell cycle is affected [8]. 
Our results clearly show that EGF efficiently counteracts he 
iNOS expression elicited by IL-lfl, and to a lower extent han 
that triggered by TNF-ct and LPS. Indeed, these results also 
provide information regarding the complexity of the molecular 
mechanisms that operate to promote iNOS expression, suggest- 
ing that cytokines uch as TNF-ct and bacterial products uch 
as LPS recruit several different signaling pathways in their 
mechanism ofaction, only part of them blocked by EGF signal- 
ing. Alternatively, the partial inhibition of EGF might be due 
to the time-limited EGF signaling because of the rapid internal- 
ization and degradation of the ligand-receptor complex of this 
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Fig. 4. EGF inhibits iNOS expression by cytokines. Primary cultures 
of hepatocytes were incubated for 6 h in the absence or presence of10 
nM EGF and l0 ng/ml of IL-lfl (lane 2), TNF-ct (lane 3) or 500 ng/ml 
of LPS (lane 4), and the mRNA was analyzed by Northern blot to 
determine iNOS expression (in arbitrary units, bottom panel). Alterna- 
tively, iNOS activity was determined in cell cultures after 24 h of 
incubation with these cytokines in the absence (open bars) or presence 
(cross-hatched bars) of EGF (right panel). Results how a representa- 
tive experiment (Northern blot) or the mean +_ S.E.M. of 3 experiments 
(enzyme activity). 
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other cytokines that inhibit iNOS expression provides alterna- 
tive mechanisms to reinforce iNOS expression blockage since 
distinct intracellular signaling pathways are involved. This is 
the case for TGF-fl that has ben reported as an inhibitor of 
iNOS expression in various cell types such as macrophages 
[22,23]. 
Finally, the regulation of iNOS expression could be con- 
trolled by the balance between cytokines that induce and re- 
press its synthesis. According to this view, the fact that liver 
expresses an important number of receptors for EGF could be 
pharmacologically exploited to specifically repress or attenuate 
liver NO production under pathological conditions (i.e. septic 
shock), 
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